Relationships between Genetic Variations of PNPLA3, TM6SF2 and Histological Features of Nonalcoholic Fatty Liver Disease in Japan.
- Author:
Norio AKUTA
1
;
Yusuke KAWAMURA
;
Yasuji ARASE
;
Fumitaka SUZUKI
;
Hitomi SEZAKI
;
Tetsuya HOSAKA
;
Masahiro KOBAYASHI
;
Mariko KOBAYASHI
;
Satoshi SAITOH
;
Yoshiyuki SUZUKI
;
Kenji IKEDA
;
Hiromitsu KUMADA
Author Information
1. Department of Hepatology, Toranomon Hospital, and Okinaka Memorial Institute for Medical Research, Tokyo, Japan. akuta-gi@umin.ac.jp
- Publication Type:Original Article
- Keywords:
Non-alcoholic fatty liver disease;
Non-alcoholic steatohepatitis;
Fibrosis stage;
Patatin-like phospholipase domain containing 3;
Transmembrane 6 superfamily member 2
- MeSH:
Asian Continental Ancestry Group;
Biological Markers;
Classification;
Diagnosis;
Fatty Liver*;
Fibrosis;
Genetic Variation*;
Genotype;
Humans;
Japan*;
Multivariate Analysis
- From:Gut and Liver
2016;10(3):437-445
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND/AIMS: It is important to determine the noninvasive parameters of histological features in nonalcoholic fatty liver disease (NAFLD). The aim of this study was to investigate the value of genetic variations as surrogate markers of histological features. METHODS: The parameters that affected the histological features of NAFLD were investigated in 211 Japanese patients with biopsy-proven NAFLD. The relationships between genetic variations in PNPLA3 rs738409 or TM6SF2 rs58542926 and histological features were analyzed. Furthermore, the impact of genetic variations that affected the pathological criteria for the diagnosis of nonalcoholic steatohepatitis (NASH) (Matteoni classification and NAFLD activity score) was evaluated. RESULTS: The fibrosis stage of PNPLA3 GG was significantly more progressive than that of CG by multiple comparisons. Multivariate analysis identified PNPLA3 genotypes as predictors of fibrosis of stage 2 or more, but the impact tended to decrease at stage 3 or greater. There were no significant differences among the histological features of the three genotypes of TM6SF2. PNPLA3 genotypes partly affected the definition of NASH by the NAFLD activity score, but TM6SF2 genotypes did not affect the definition of NASH. CONCLUSIONS: In Japanese patients with biopsy-proven NAFLD, PNPLA3 genotypes may partly affect histological features, including stage of fibrosis, but the TM6SF2 genotype does not affect histological features.
